ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1532

Serum Angiopoietin-2 Level Reflects the Disease Activity and Renal Function in Antineutrophilic Cytoplasmic Antibody-Associated Vasculitis

Yoko Wada1, Hiroe Sato1, Takeshi Nakatsue1, Shuichi Murakami1, Takeshi Kuroda2, Masaaki Nakano3 and Ichiei Narita1, 1Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 2Health Administration Center, Niigata University, Niigata, Japan, 3School of Health Sciences, Faculty of Medicine, Niigata University, Niigata, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: ANCA, angiopoietin and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Angiopoietin-2 (Ang-2) has emerged as a key mediator of endothelial cell activation. Ang-1 and Ang-2 are antagonistic ligands which bind with similar affinity to the extracellular domain of the tyrosine kinase with Ig-like and epidermal growth factor-like domains 2 (Tie-2) receptor, which is almost exclusively expressed by endothelial cells. Ang-1/Tie-2 signalling maintains vessel integrity, inhibits vascular leakage, suppresses inflammatory gene expression and prevents recruitment and transmigration of leukocytes. In contrast, binding of Ang-2 disrupts protective Ang-1/Tie-2 signalling and facilitates endothelial inflammation. Recently, serum Ang-2 levels have been reported to be elevated in autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus, and ANCA-associated vasculitis (AAV). The purpose of this study is to examine the serum Ang-2 levels in patients with AAV, and investigate the relationship with the clinical and laboratory findings.

Methods: Fifty-nine patients with AAV (microscopic polyangitis (MPA, n=27), granulomatosis with polyangitis (GPA, n=15), Churg-Strauss syndrome (CSS, n=14), others (n=3)), who had been referred to Niigata University Medical and Dental Hospital between 2000 and 2011, were enrolled in this study. Written informed consent was obtained from each participant. The patients were divided into 2 groups according to their disease activities using Birminghamvasculitis activity score (BVAS) (active disease group (AD group, n=45) and remission disease group (RD group, n=14)) Serum Ang-2 levels and laboratory findings were examined in each subject, and the data were compared between these 2 groups. The data from all subjects were analyzed using Spearman’s rank correlation coefficient to determine the relationship with serum Ang-2 levels. Next, the patients with AD group were divided into 2 groups in accordance with their stages of chronic kidney diseases (CKD) (CKD<3 group, n=19, and CKD≥3 group, n=26), and the data were compared to examine the impact of renal function in this study.

Results:  The serum Ang-2 level, C-reactive protein (CRP), white blood cell count, and urinary protein excretion were significantly higher in AD group compared with those in RD group. In Spearman’s rank correlation coefficient analysis using data from all subjects, the serum Ang-2 level was positively correlated with BVAS (r=0.62, p<0.0001), CRP (r=0.47, p=0.0003), serum creatinine (Cr) (r=0.38, p=0.005), and urinary protein excretion (UP) (r=0.55, p<0.0001), and negatively correlated with estimated glomerular filtration rate (r=-0.37, p=0.005). In the next analysis, patients in CKD≥3 were significantly elder and BVAS was significantly higher compared to those with patients in CKD<3 group. Ang-2 was elevated in CKD≥3 group without statistical significance. In Spearman’s rank correlation coefficient analysis, Ang-2 was positively correlated with CRP and BVAS in CKD<3 group, while it was correlated with UP, e-GFR, Cr, and CRP in CKD≥3 group.

Conclusion: Serum Ang-2 level was strongly correlated with the disease activity and renal function in AAV. These results indicated the possible role of Ang-2 in the development of AAV through endothelial injuries.


Disclosure:

Y. Wada,
None;

H. Sato,
None;

T. Nakatsue,
None;

S. Murakami,
None;

T. Kuroda,
None;

M. Nakano,
None;

I. Narita,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/serum-angiopoietin-2-level-reflects-the-disease-activity-and-renal-function-in-antineutrophilic-cytoplasmic-antibody-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology